GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (NSE:KILITCH) » Definitions » Pre-Tax Income

Kilitch Drugs (India) (NSE:KILITCH) Pre-Tax Income : ₹201 Mil (TTM As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Kilitch Drugs (India) Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Kilitch Drugs (India)'s pretax income for the three months ended in Sep. 2024 was ₹103 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was ₹201 Mil. Kilitch Drugs (India)'s pretax margin was 21.79%.

During the past 13 years, Kilitch Drugs (India)'s highest Pretax Margin was 12.83%. The lowest was -55.41%. And the median was 8.01%.


Kilitch Drugs (India) Pre-Tax Income Historical Data

The historical data trend for Kilitch Drugs (India)'s Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) Pre-Tax Income Chart

Kilitch Drugs (India) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.07 51.20 96.14 120.14 193.55

Kilitch Drugs (India) Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.83 28.23 52.97 16.50 103.46

Competitive Comparison of Kilitch Drugs (India)'s Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kilitch Drugs (India)'s Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Kilitch Drugs (India)'s Pre-Tax Income falls into.



Kilitch Drugs (India) Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Kilitch Drugs (India)'s Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=211.106+0+-59.294+4.079+37.654
=194

Kilitch Drugs (India)'s Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=54.877+0+-3.055+0+51.642
=103

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹201 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kilitch Drugs (India)  (NSE:KILITCH) Pre-Tax Income Explanation

Kilitch Drugs (India)'s Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=103.464/474.749
=21.79%

During the past 13 years, Kilitch Drugs (India)'s highest Pretax Margin was 12.83%. The lowest was -55.41%. And the median was 8.01%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kilitch Drugs (India) Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Kilitch Drugs (India) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines